source
- FDA schedules September advisory panel to review Grail's cancer test after trial missThe FDA announced it will hold an advisory committee meeting in September to examine Grail's multi‑cancer early detection test. The test recently failed to meet its primary endpoint in a large, ra…
- Biopharma job postings rise 15% in Q2 as layoffs fall and M&A activity picks upThe Q2 2026 BioSpace report shows a strengthening biopharma job market, with more openings and fewer layoffs compared with the prior year. Job postings on BioSpace were up 15% year-over-year and 1…